Lemaitre Vascular [LMAT] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
Lemaitre Vascular
NASDAQ
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lemaitre Vascular wins in 9 metrics, Intuitive Surgical wins in 10 metrics, with 0 ties. Intuitive Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lemaitre Vascular | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 46.04 | 66.69 | Lemaitre Vascular |
| Price-to-Book Ratio | 5.89 | 9.60 | Lemaitre Vascular |
| Debt-to-Equity Ratio | 51.25 | 0.00 | Intuitive Surgical |
| PEG Ratio | 43.49 | 60.84 | Lemaitre Vascular |
| EV/EBITDA | 30.26 | 51.46 | Lemaitre Vascular |
| Profit Margin (TTM) | 20.08% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | 25.13% | 30.47% | Intuitive Surgical |
| EBITDA Margin (TTM) | 25.13% | 30.47% | Intuitive Surgical |
| Return on Equity | 13.81% | 16.04% | Intuitive Surgical |
| Return on Assets (TTM) | 7.28% | 9.02% | Intuitive Surgical |
| Free Cash Flow (TTM) | $37.16M | $1.30B | Intuitive Surgical |
| Dividend Yield | 0.98% | N/A | N/A |
| 1-Year Return | 9.29% | -1.49% | Lemaitre Vascular |
| Price-to-Sales Ratio (TTM) | 9.11 | 18.74 | Lemaitre Vascular |
| Enterprise Value | $1.96B | $163.93B | Intuitive Surgical |
| EV/Revenue Ratio | 8.37 | 17.93 | Lemaitre Vascular |
| Gross Profit Margin (TTM) | 70.02% | 66.31% | Lemaitre Vascular |
| Revenue per Share (TTM) | $10 | $26 | Intuitive Surgical |
| Earnings per Share (Diluted) | $2.05 | $7.17 | Intuitive Surgical |
| Beta (Stock Volatility) | 0.79 | 1.60 | Lemaitre Vascular |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lemaitre Vascular vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | 1.90% | 10.26% | 12.24% | 14.46% | -2.01% | 3.18% |
| Intuitive Surgical | 1.34% | 0.25% | -7.41% | -14.83% | -18.90% | -8.75% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | 9.29% | 78.80% | 216.43% | 587.60% | 1,305.46% | 1,335.97% |
| Intuitive Surgical | -1.49% | 109.92% | 104.01% | 737.80% | 1,346.95% | 5,591.80% |
Performance & Financial Health Analysis: Lemaitre Vascular vs Intuitive Surgical
| Metric | LMAT | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $2.14B | $171.42B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 212,414 | 2,080,522 |
| 90 Day Avg. Volume | 141,971 | 2,007,747 |
| Last Close | $94.38 | $478.19 |
| 52 Week Range | $71.42 - $109.58 | $425.00 - $616.00 |
| % from 52W High | -13.87% | -22.37% |
| All-Time High | $109.58 (Nov 25, 2024) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -13.87% | -22.37% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.21% |
| Quarterly Earnings Growth | 0.17% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.29% |
| Operating Margin (TTM) | 0.25% | 0.30% |
| Return on Equity (TTM) | 0.14% | 0.16% |
| Debt to Equity (MRQ) | 51.25 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.02 | $49.79 |
| Cash per Share (MRQ) | $14.11 | $14.86 |
| Operating Cash Flow (TTM) | $58.76M | $2.83B |
| Levered Free Cash Flow (TTM) | $37.70M | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.98% | N/A |
| Last 12-Month Dividend | $0.92 | N/A |
Valuation & Enterprise Metrics Analysis: Lemaitre Vascular vs Intuitive Surgical
| Metric | LMAT | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 46.04 | 66.69 |
| Forward P/E | 43.49 | 60.84 |
| PEG Ratio | 43.49 | 60.84 |
| Price to Sales (TTM) | 9.11 | 18.74 |
| Price to Book (MRQ) | 5.89 | 9.60 |
| Market Capitalization | ||
| Market Capitalization | $2.14B | $171.42B |
| Enterprise Value | $1.96B | $163.93B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.37 | 17.93 |
| Enterprise to EBITDA | 30.26 | 51.46 |
| Risk & Other Metrics | ||
| Beta | 0.79 | 1.60 |
| Book Value per Share (MRQ) | $16.02 | $49.79 |
Financial Statements Comparison: Lemaitre Vascular vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LMAT | ISRG |
|---|---|---|
| Revenue/Sales | $59.87M | $2.44B |
| Cost of Goods Sold | $18.45M | $822.10M |
| Gross Profit | $41.42M | $1.62B |
| Research & Development | $4.10M | $313.30M |
| Operating Income (EBIT) | $12.63M | $743.40M |
| EBITDA | $18.08M | $898.70M |
| Pre-Tax Income | $14.24M | $832.10M |
| Income Tax | $3.23M | $167.90M |
| Net Income (Profit) | $11.01M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LMAT | ISRG |
|---|---|---|
| Cash & Equivalents | $25.34M | $2.57B |
| Total Current Assets | $408.11M | $7.66B |
| Total Current Liabilities | $24.75M | $1.54B |
| Long-Term Debt | $182.73M | N/A |
| Total Shareholders Equity | $347.57M | $17.21B |
| Retained Earnings | $151.58M | $7.14B |
| Property, Plant & Equipment | $41.34M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LMAT | ISRG |
|---|---|---|
| Operating Cash Flow | $5.69M | $833.10M |
| Capital Expenditures | $-1.38M | $-116.60M |
| Free Cash Flow | $7.66M | $465.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LMAT | ISRG |
|---|---|---|
| Shares Short | 1.33M | 4.30M |
| Short Ratio | 12.47 | 2.18 |
| Short % of Float | 0.08% | 0.01% |
| Average Daily Volume (10 Day) | 212,414 | 2,080,522 |
| Average Daily Volume (90 Day) | 141,971 | 2,007,747 |
| Shares Outstanding | 22.55M | 356.60M |
| Float Shares | 20.80M | 356.33M |
| % Held by Insiders | 0.08% | 0.01% |
| % Held by Institutions | 0.94% | 0.89% |
Dividend Analysis & Yield Comparison: Lemaitre Vascular vs Intuitive Surgical
| Metric | LMAT | ISRG |
|---|---|---|
| Last 12-Month Dividend | $0.92 | N/A |
| Last 12-Month Dividend Yield | 0.98% | N/A |
| 3-Year Avg Annual Dividend | $0.68 | N/A |
| 3-Year Avg Dividend Yield | 0.23% | N/A |
| 3-Year Total Dividends | $2.04 | N/A |
| Ex-Dividend Date | Aug 21, 2025 | N/A |